AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ICONIC LABS PLC

Capital/Financing Update Sep 9, 2024

4953_rns_2024-09-09_7a39eade-d188-4d01-b966-1740a970f9e4.html

Capital/Financing Update

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3124D

Iconic Labs PLC

09 September 2024

Iconic Labs PLC

("Iconic" or the "Company")

Waiver of Event of Default

Iconic Labs PLC (LSE: ICON)  today provides an update in respect of the loan notes ("Loan Notes") held by the European High Growth Opportunities Securitization Fund ("EHGO") and Arch Capital Partners LLP, formerly known as Linton Capital LLP, ("Arch").

The listing in the Company's shares has been suspended since 28 February 2024 ("Suspension").  On 11 March 2024, the Company announced the signing of non-binding heads of terms in connection with the potential purchase of the entire issued share capital of ITS Holdings 2023 Ltd (the "Target"), the owner of In The Style Fashion Limited, an online fashion retailer. The proposed transaction is, inter alia, conditional on the completion of legal and financial due diligence on the Target and if completed would constitute a reverse takeover  under the UK Listing Rules ("Reverse Takeover").

Under the terms of the Loan Notes, the Suspension would trigger an event of default. Arch and EHGO wish to give the Company additional time to complete the Reverse Takeover and have therefore agreed to waive the event of default ("Waiver") provided that the suspension is lifted on or prior to 31 December 2024. In consideration for the Waiver, Iconic shall issue £60,000 loan notes (the "Waiver Fee Notes"). The subscription price of the Waiver Fee Notes shall be paid by Arch by way of set-off against certain, liquid and due receivables held by Arch against the Company.

The Company confirms that it continues to work with its advisers to progress the legal and financial due diligence to enable the Reverse Takeover to proceed and will provide further updates in due course.

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).   

- Ends -

For more information, please contact:

Iconic Labs

John Farquharson
via Yellow Jersey PR
Novum Securities Limited

David Coffman / Daniel Harris
Tel: +44 (0) 20 7399 9400
Yellow Jersey PR

Charles Goodwin

Annabelle Wills

Bessie Elliot
Tel: +44 (0) 20 3004 9512

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUNUNRSSUKRAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.